BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11953374)

  • 1. Identification and cloning of a cryptococcal deacetylase that produces protective immune responses.
    Biondo C; Beninati C; Delfino D; Oggioni M; Mancuso G; Midiri A; Bombaci M; Tomaselli G; Teti G
    Infect Immun; 2002 May; 70(5):2383-91. PubMed ID: 11953374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Cryptococcus neoformans gene DHA1 encodes an antigen that elicits a delayed-type hypersensitivity reaction in immune mice.
    Mandel MA; Grace GG; Orsborn KI; Schafer F; Murphy JW; Orbach MJ; Galgiani JN
    Infect Immun; 2000 Nov; 68(11):6196-201. PubMed ID: 11035725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T cell responses to Cryptococcus neoformans.
    Levitz SM; Nong S; Mansour MK; Huang C; Specht CA
    Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10422-7. PubMed ID: 11504924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with Recombinant
    Specht CA; Lee CK; Huang H; Hester MM; Liu J; Luckie BA; Torres Santana MA; Mirza Z; Khoshkenar P; Abraham A; Shen ZT; Lodge JK; Akalin A; Homan J; Ostroff GR; Levitz SM
    mBio; 2017 Nov; 8(6):. PubMed ID: 29184017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8 cells play a critical role in delayed type hypersensitivity to intact Cryptococcus neoformans.
    Mody CH; Paine R; Jackson C; Chen GH; Toews GB
    J Immunol; 1994 Apr; 152(8):3970-9. PubMed ID: 8144964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of a second immunoreactive mannoprotein from Cryptococcus neoformans that stimulates T-Cell responses.
    Huang C; Nong SH; Mansour MK; Specht CA; Levitz SM
    Infect Immun; 2002 Oct; 70(10):5485-93. PubMed ID: 12228274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of two novel cryptococcal mannoproteins recognized by immune sera.
    Biondo C; Messina L; Bombaci M; Mancuso G; Midiri A; Beninati C; Cusumano V; Gerace E; Papasergi S; Teti G
    Infect Immun; 2005 Nov; 73(11):7348-55. PubMed ID: 16239533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of T helper type 1 responses by a polysaccharide deacetylase from Cryptococcus neoformans.
    Biondo C; Beninati C; Bombaci M; Messina L; Mancuso G; Midiri A; Galbo R; Teti G
    Infect Immun; 2003 Sep; 71(9):5412-7. PubMed ID: 12933895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a third-order suppressor T cell (Ts3) induced by cryptococcal antigen(s).
    Khakpour FR; Murphy JW
    Infect Immun; 1987 Jul; 55(7):1657-62. PubMed ID: 2954914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of an immunogenic cellulase secreted by Cryptococcus pathogens.
    Midiri A; Mancuso G; Lentini G; Famà A; Galbo R; Zummo S; Giardina M; De Gaetano GV; Teti G; Beninati C; Biondo C
    Med Mycol; 2020 Nov; 58(8):1138-1148. PubMed ID: 32246714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of Protective Immunity to Cryptococcal Infection in Mice by a Heat-Killed, Chitosan-Deficient Strain of Cryptococcus neoformans.
    Upadhya R; Lam WC; Maybruck B; Specht CA; Levitz SM; Lodge JK
    mBio; 2016 May; 7(3):. PubMed ID: 27165801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in components at delayed-type hypersensitivity reaction sites in mice immunized with either a protective or a nonprotective immunogen of Cryptococcus neoformans.
    Nichols KL; Bauman SK; Schafer FB; Murphy JW
    Infect Immun; 2002 Feb; 70(2):591-600. PubMed ID: 11796587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.
    Specht CA; Lee CK; Huang H; Tipper DJ; Shen ZT; Lodge JK; Leszyk J; Ostroff GR; Levitz SM
    mBio; 2015 Dec; 6(6):e01905-15. PubMed ID: 26695631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of protective inflammation and cell-mediated immunity against Cryptococcus neoformans after exposure to hyphal mutants.
    Zhai B; Wozniak KL; Masso-Silva J; Upadhyay S; Hole C; Rivera A; Wormley FL; Lin X
    mBio; 2015 Oct; 6(5):e01433-15. PubMed ID: 26443458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tumor necrosis factor alpha on dendritic cell accumulation in lymph nodes draining the immunization site and the impact on the anticryptococcal cell-mediated immune response.
    Bauman SK; Huffnagle GB; Murphy JW
    Infect Immun; 2003 Jan; 71(1):68-74. PubMed ID: 12496150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related resistance of C57BL/6 mice to Cryptococcus neoformans is dependent on maturation of NKT cells.
    Blackstock R; Murphy JW
    Infect Immun; 2004 Sep; 72(9):5175-80. PubMed ID: 15322012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenic fractions of Cryptococcus neoformans.
    Graybill JR; Straus DC; Nealon TJ; Hague M; Paque RE
    Mycopathologia; 1982 Apr; 78(1):31-9. PubMed ID: 7048099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles for CD40, B7 and major histocompatibility complex in induction of enhanced immunity by cryptococcal polysaccharide-pulsed antigen-presenting cells.
    Blackstock R
    Immunology; 2003 Feb; 108(2):158-66. PubMed ID: 12562324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomes, a potential immunoadjuvant and carrier for a cryptococcal vaccine.
    Lambros MP; Schafer F; Blackstock R; Murphy JW
    J Pharm Sci; 1998 Sep; 87(9):1144-8. PubMed ID: 9724568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cells in the induction of protective and nonprotective anticryptococcal cell-mediated immune responses.
    Bauman SK; Nichols KL; Murphy JW
    J Immunol; 2000 Jul; 165(1):158-67. PubMed ID: 10861048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.